Since STAT2 can form a complex with IRF9 and induce the expression of ISGs in the absence of STAT1, which seems to be tissue‐ and context‐dependent [48], we next silenced STAT2 in CAF1 before adding the CM from treated cancer cells. The gene discussed is IRF9; the disease is cancer.